Glioblastoma is a aggressive brain cancer known for its rapid growth and unresponsiveness to conventional treatments. Studies are constantly underway to identify new therapeutic strategies, and recently, a unique biomarker named LCA168 has emerged as a potential focus for glioblastoma treatment. LCA168 is a protein that is abundantly produced in g… Read More